Search research articles
Contact Us
Filters
Showing results (541-550 of 570) with videos related to
Page
of 57
Sort By:
Thrombosis and Haemostasis
|
December 8, 1998
French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance
C Rothschild, Y Laurian, E P Satre, et al.
Plos One
|
March 19, 2015
Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study
Eric O Johnson, Dana B Hancock, Nathan C Gaddis, et al.
Leukemia
|
August 6, 2016
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study
P Moreau, D Joshua, W-J Chng, et al.
Leukemia
|
December 28, 2016
Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR
W-J Chng, H Goldschmidt, M A Dimopoulos, et al.
ESMO Open
|
May 9, 2022
Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study
C Baldini, E Charton, E Schultz, et al.
Leukemia
|
April 6, 2013
Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma
X Leleu, G Fouquet, B Hebraud, et al.
ESMO Open
|
August 3, 2023
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study
E Charton, C Baldini, Y Fayet, et al.
Bone Marrow Transplantation
|
May 29, 1998
Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registry
P Moreau, J Fleury, P Brice, et al.
Human Immunology
|
January 4, 2001
HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression
P Paul, N Rouas-Freiss, P Moreau, et al.
Leukemia
|
July 30, 2011
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
S K Kumar, J H Lee, J J Lahuerta, et al.
Page
of 57
Search research articles
Search
Showing results (541-550 of 570) with videos related to
Sort By:
Page
of 57
Thrombosis and Haemostasis
|
December 8, 1998
French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance
C Rothschild, Y Laurian, E P Satre, et al.
Plos One
|
March 19, 2015
Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study
Eric O Johnson, Dana B Hancock, Nathan C Gaddis, et al.
Leukemia
|
August 6, 2016
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study
P Moreau, D Joshua, W-J Chng, et al.
Leukemia
|
December 28, 2016
Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR
W-J Chng, H Goldschmidt, M A Dimopoulos, et al.
ESMO Open
|
May 9, 2022
Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study
C Baldini, E Charton, E Schultz, et al.
Leukemia
|
April 6, 2013
Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma
X Leleu, G Fouquet, B Hebraud, et al.
ESMO Open
|
August 3, 2023
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study
E Charton, C Baldini, Y Fayet, et al.
Bone Marrow Transplantation
|
May 29, 1998
Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registry
P Moreau, J Fleury, P Brice, et al.
Human Immunology
|
January 4, 2001
HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression
P Paul, N Rouas-Freiss, P Moreau, et al.
Leukemia
|
July 30, 2011
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
S K Kumar, J H Lee, J J Lahuerta, et al.
Page
of 57